Showing results (91-100 of 139) with videos related to
Sort By:
Pageof 14
Human Vaccines & Immunotherapeutics|October 27, 2017
Socioeconomic inequality in Hepatitis B vaccination of rural adults in ChinaDawei Zhu, Na Guo, Jian Wang, et al.Health Research Policy and Systems|January 4, 2022
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?Cong Huang, Carolina Oi Lam Ung, Haishaerjiang Wushouer, et al.Autoimmunity Reviews|June 2, 2026
Comparison of treatment effects between ACR response criteria and target-based outcomes for contemporary rheumatoid arthritis drug approval trials: A meta-epidemiological studyWengliang Dong, Gengchen Wang, Xiaowen Hu, et al.Antibiotics (Basel, Switzerland)|December 23, 2023
Exploring Facilitators and Barriers to Delayed Antibiotic Prescribing in Rural Northwest China: A Qualitative Study Using the Theoretical Domains Framework and Behavior Change WheelHaishaerjiang Wushouer, Weihsin Ko, Kexin Du, et al.Neurology|March 27, 2025
Statin Use and Risk of Intracerebral Hemorrhage in Chinese Population: A Target Trial Emulation StudyDongze Ji, Shujie Dong, Tiansheng Wang, et al.The Lancet. Infectious Diseases|March 23, 2025
The burden of β-lactam allergy labels in health care: a systematic review and meta-analysisMengyuan Fu, Lin Hu, Kexin Han, et al.The Lancet. Oncology|August 9, 2025
Strength of evidence supporting cancer drug approvals in China between 2017 and 2021: a retrospective analysisYichen Zhang, Dingyi Chen, Mengyuan Fu, et al.Frontiers in Pharmacology|March 17, 2022
Clinical Outcome and Medical Cost of Originator and Generic Antihypertensive Drugs: A Population-Based Study in Yinzhou, ChinaTao Huang, Lin Bai, Haishaerjiang Wushouer, et al.BMJ Global Health|November 29, 2023
Sponsorship bias in published pharmacoeconomic evaluations of national reimbursement negotiation drugs in China: a systematic reviewZixuan He, Xianqin Huang, Dingyi Chen, et al.Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|October 24, 2025
[Impact of palliative care on medication use and medical utilization in patients with advanced cancer]Dingyi Chen, Haoxin DU, Yichen Zhang, et al.Pageof 14